Cineworld shares: bull vs bear

We believe that considering a diverse range of insights makes us better investors. Here, two contributors debate Cineworld shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Bullish: Manika Premsingh

Multinational cinema operator Cineworld (LSE: CINE) went through a rough time in the pandemic. And unlike many other pandemic-impacted stocks, its share price has still not returned to pre-pandemic levels. It is highly sensitive to any Covid-19 related developments, which could potentially bring its business to a grinding halt in a flash, like it did last year.

Yet, I have been bullish on the stock for a while now and have even bought it. The reason is not hard to guess. It is one of my recovery picks, because I think that cinemas could boom as the pandemic recedes and the recovery takes hold.

Already, there are signs of improvement in Cineworld’s performance. As per its latest trading update, the company’s revenues in October were back to 90% of their pre-pandemic levels of 2019. The numbers for the UK and Ireland are particularly encouraging, since they have actually surpassed the 2019 revenues.

The rest of 2021 also looks good for it, with blockbusters like Spider-Man: No Way Home, The Matrix Resurrections and Sing 2 slated for release. 2022 is expected to be dotted with big releases as well, including those that were delayed because of Covid-19. So there is little reason to doubt, in my view, that the FTSE 250 stock could be in much better shape by this time next year.

There could be stumbling blocks along the way ,of course. It has a mountain of debt to pay off, the pandemic is still something of a challenge, and rising inflation could slow down recovery significantly, which could impact investor sentiment. On the whole, though, I am optimistic for Cineworld.

Manika Premsingh owns shares of Cineworld


Bearish: Paul Summers

I’ve been bearish on Cineworld shares for as long as I can remember. Based on the sheer number of headwinds faced by the company, I can’t see this changing any time soon.

This stance might seem odd considering the success of No Time to Die and the encouraging slate of films due for release in 2022 (including Matrix 4, Top Gun 2 and Jurassic World: Dominion). But let’s be realistic. Like the stock market, nothing is guaranteed in the movie world. Nailed-on blockbusters can be poorly received. Even better-than-expected weather can impact Cineworld’s earnings. This makes the industry pretty risky for investors, in my opinion.

In addition to this, you have the seemingly perpetual rise of streaming services such as Netflix and Amazon Prime. The shorter window of opportunity Cineworld now has between a film being shown on the silver screen and being available to watch from the comfort of my own home is worrying.

By far Cineworld’s biggest problem, however, is that massive debt pile. Even if the pandemic is nearing its final chapter, that burden will still take a long time to shift. This may be the reason why the company is easily the most shorted stock on the UK market.

The cinema operator might have the potential to make money for traders nipping in and out of positions. For a long-term investor like me, however, Cineworld simply doesn’t make the grade. 

Paul Summers has no position in any of the shares mentioned.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool UK has recommended Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »